http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2008255191-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727
filingDate 2008-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40d3348147b720beca01a4846325d345
publicationDate 2010-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2008255191-A1
titleOfInvention Use of Ave5026 for minimizing the incidence of bleedings during an antithrombotic treatment
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012152918-A1
priorityDate 2008-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282448
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425987458
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32756
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3513851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536181
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419563342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID772

Total number of triples: 23.